198 related articles for article (PubMed ID: 9841603)
1. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial.
Ohkusa T; Takashimizu I; Fujiki K; Suzuki S; Shimoi K; Horiuchi T; Sakurazawa T; Ariake K; Ishii K; Kumagai J; Tanizawa T
Ann Intern Med; 1998 Nov; 129(9):712-5. PubMed ID: 9841603
[TBL] [Abstract][Full Text] [Related]
2. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.
Ji F; Wang ZW; Ning JW; Wang QY; Chen JY; Li YM
World J Gastroenterol; 2006 Mar; 12(11):1770-3. PubMed ID: 16586550
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases.
Ohkusa T; Miwa H; Hojo M; Kumagai J; Tanizawa T; Asaoka D; Terai T; Ohkura R; Sato N
Digestion; 2003; 68(2-3):57-62. PubMed ID: 14581761
[TBL] [Abstract][Full Text] [Related]
4. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen.
Adachi K; Ishihara S; Hashimoto T; Hirakawa K; Ishimura N; Niigaki M; Kaji T; Kawamura A; Sato H; Fujishiro H; Hattori S; Watanabe M; Kinoshita Y
Aliment Pharmacol Ther; 2001 Aug; 15(8):1187-91. PubMed ID: 11472321
[TBL] [Abstract][Full Text] [Related]
6. Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Shimoyama T; Fukuda Y; Fukuda S; Munakata A; Yoshida Y; Shimoyama T
J Gastroenterol; 1996 Nov; 31 Suppl 9():59-62. PubMed ID: 8959522
[TBL] [Abstract][Full Text] [Related]
7. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
8. High-dose ecabet sodium improves the eradication rate of helicobacter pylori in dual therapy with lansoprazole and amoxicillin.
Kagaya H; Kato M; Komatsu Y; Mizushima T; Sukegawa M; Nishikawa K; Hokari K; Takeda H; Sugiyama T; Asaka M
Aliment Pharmacol Ther; 2000 Nov; 14(11):1523-7. PubMed ID: 11069325
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
10. Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.
Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Shimoyama T
J Clin Gastroenterol; 1995; 20 Suppl 2():S132-5. PubMed ID: 7594330
[TBL] [Abstract][Full Text] [Related]
11. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial.
Nam SY; Lee SW; Jeon SW; Kwon YH; Lee HS
Dig Dis Sci; 2020 Dec; 65(12):3652-3659. PubMed ID: 31974914
[TBL] [Abstract][Full Text] [Related]
13. Healing of cimetidine-resistant Ménétrier's disease by eradication of Helicobacter pylori infection.
Shimoyama T; Fukuda S; Tanaka M; Mikami T; Yamagata R; Yoshimura T; Haga Y; Murata Y; Munakata A
J Clin Gastroenterol; 1998 Dec; 27(4):348-50. PubMed ID: 9855268
[TBL] [Abstract][Full Text] [Related]
14. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
15. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
16. Disappearance of multiple hyperplastic polyps after the eradication of Helicobacter pylori.
Suzuki S; Ohkusa T; Shimoi K; Horiuchi T; Fujiki K; Takashimizu I
Gastrointest Endosc; 1997 Dec; 46(6):566-8. PubMed ID: 9434232
[No Abstract] [Full Text] [Related]
17. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
18. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
[TBL] [Abstract][Full Text] [Related]
19. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps.
Ljubicić N; Banić M; Kujundzić M; Antić Z; Vrkljan M; Kovacević I; Hrabar D; Doko M; Zovak M; Mihatov S
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):727-30. PubMed ID: 10445791
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
Schwizer W; Thumshirn M; Dent J; Guldenschuh I; Menne D; Cathomas G; Fried M
Lancet; 2001 Jun; 357(9270):1738-42. PubMed ID: 11403809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
